U.S. Biotech Stock News

Array Technologies (ARRY) has been in focus after a sharp business recovery, marked by strong revenue growth, sizeable bookings and the APA acquisition. Together, these developments have shifted how many investors view the stock. See our latest analysis for Array Technologies. Those operational headlines have been reflected in the trading pattern, with a 14.68% 30 day share price return and a 9.83% 90 day gain, even though the year to date share price return is slightly negative and the 3...

Why STAAR Surgical Is Back in Focus After the Failed Alcon Deal STAAR Surgical (STAA) is back on investors’ radar after shareholders rejected its cash sale to Alcon and the company confirmed it will continue as an independent, publicly traded business. That decision has quickly been followed by a broad refresh of the boardroom, new committee structures and an active search for a new chief executive, all with heavy involvement from STAAR’s largest shareholders. See our latest analysis for...

AZZ Inc. recently reported third-quarter fiscal 2026 results showing higher sales of US$425.75 million and net income of US$41.08 million year on year, while also narrowing full-year revenue guidance to US$1.625 billion–US$1.7 billion, authorizing a US$0.20 per share dividend, and completing a share buyback of 1,134,067 shares since 2020. Management highlighted strong momentum in Metal Coatings, an active pipeline of small bolt-on acquisitions, and ongoing capital returns via dividends and...

Why Worthington Enterprises is on investors’ radar today Worthington Enterprises (WOR) has been drawing attention after a mixed stretch in recent trading, with the share price drifting lower over the past month and past 3 months while longer term returns remain positive. See our latest analysis for Worthington Enterprises. At around US$53.43, the share price has eased in the short term, with a 1 day share price return of a 2.0% decline and a 90 day share price return of a 5.5% decline, while...

Wells Fargo’s Ike Boruchow recently upgraded Burlington Stores (BURL) to a buy rating, a move that has sharpened investor focus on how the off price retailer’s fundamentals compare with this renewed optimism. See our latest analysis for Burlington Stores. The recent upgrade lands after a strong short term run, with a 30 day share price return of 14.22% and a 90 day share price return of 11.57%, while the latest close sits at US$306.31. At the same time, the 1 year total shareholder return of...

Why ERAS-0015 trial data is moving Erasca (ERAS) into focus Erasca (ERAS) has drawn fresh attention after early data from its AURORAS-1 Phase 1 trial for ERAS-0015, presented at the JP Morgan Healthcare Conference, showed partial responses and a clean safety profile in RAS-mutated tumors. The company reported two confirmed partial responses and one unconfirmed partial response at a low 8 mg once daily dose, with no dose-limiting toxicities and largely low grade side effects across evaluated...

Recent performance snapshot for RadNet With no single headline event driving RadNet (RDNT) today, the stock’s recent performance offers useful context, including a 1 day return of about a 3% decline and a past 3 months return near an 8% decline. See our latest analysis for RadNet. At the current share price of US$70.99, RadNet’s recent 7 day and 90 day share price declines sit against a much stronger backdrop, with 1 year total shareholder return of 18.59% and very large 3 and 5 year total...

Why VeriSign (VRSN) Is On Investors’ Radar Today VeriSign (VRSN) is back in focus after recent share price moves, with the stock showing mixed short and longer term returns while sitting on annual revenue of US$1.63b and net income of US$811.0m. See our latest analysis for VeriSign. At a share price of US$249.47, VeriSign has logged a 2.61% 1 month share price return, while its 1 year total shareholder return of 19.99% points to momentum that has held up even as the 3 month share price return...

Event context and why it matters for PureCycle PureCycle Technologies (PCT) is in focus after partnering with Churchill Container and 4ocean to supply reusable Run It Back souvenir cups made with its recycled resin at the College Football Playoff National Championship. The program ties every 20 cups sold to the removal of one pound of ocean trash, giving PureCycle a high profile platform for its recycling technology and putting a clear environmental metric in front of fans and investors. See...

Multiple large research firms have recently reaffirmed or upgraded their views on Lowe's Companies (LOW), citing the retailer's focus on operational efficiency, potential for margin improvement, growth in professional customers, and continued investment in digital capabilities. See our latest analysis for Lowe's Companies. Lowe's share price has been gaining momentum, with a 30 day share price return of 11.93% and a year to date share price return of 12.42%. The 5 year total shareholder...

M&T Bank (MTB) closed out FY 2025 with fourth quarter revenue of US$2.4 billion and basic EPS of US$4.71, alongside net income of US$718 million, framing a year where the trailing 12 month tally reached US$9.2 billion of revenue and US$17.10 in EPS. Over the past few quarters, revenue has moved from US$2.2 billion in Q4 2024 to US$2.4 billion in Q4 2025, while quarterly EPS increased from US$3.88 to US$4.71, supported by higher net income. This sets up a results season in which investors are...

In early January 2026, Rapport Therapeutics announced past and planned advances across its clinical pipeline, including preparing a Phase 3 program for RAP-219 in focal onset seizures, expanding into primary generalized tonic-clonic seizures, and resuming its Phase 2 diabetic peripheral neuropathic pain trial after the FDA lifted a clinical hold. A key insight is that Rapport is concentrating resources on programs it believes can meaningfully address unmet neurological needs while supporting...

Peabody Energy (BTU) has drawn fresh attention after President and CEO Jim Grech was appointed Chair of the National Coal Council, an advisory body to the U.S. Secretary of Energy on coal policy. See our latest analysis for Peabody Energy. The leadership spotlight from Jim Grech’s new policy role comes alongside strong recent momentum, with a 27.58% 1 month share price return and a 91.52% 1 year total shareholder return at a latest share price of $36.36. If Peabody’s recent move has you...

If you are wondering whether SS&C Technologies Holdings at around US$85.78 is offering fair value or a potential mispricing, you are in the right place. The share price has been relatively steady in the short term, with a 1.4% decline over the last 7 days and a 1.1% decline over the last 30 days, while the 1 year return sits at 10.6% and the 3 year return at 59.0%. These moves sit alongside ongoing interest in SS&C as a major software and services provider to financial institutions, with...

Executive Changes Put Dow (DOW) Leadership in Focus Dow (DOW) has drawn fresh attention after announcing upcoming leadership changes in its technology and board ranks. These developments arrive as investors reassess exposure to large US materials and plastics producers. See our latest analysis for Dow. At a share price of US$27.57, Dow’s recent 30 day share price return of 19.51% and 90 day share price return of 25.95% sit in sharp contrast to its 1 year total shareholder return of 27.80% and...

Leadership and Platform Moves Put LPL Financial Holdings (LPLA) in Focus LPL Financial Holdings (LPLA) has been active on multiple fronts, appointing new senior leaders in corporate strategy and digital expertise, while also adding acquired and affiliated advisory firms to its already sizable independent platform. See our latest analysis for LPL Financial Holdings. Recent leadership hires, new advisory firm additions and ongoing legal disputes around advisor movement have played out against a...

In recent months, Reshop announced that a growing group of lifestyle and fashion brands, including Steve Madden, have adopted its instant refund technology, which issues shoppers refunds immediately rather than after traditional processing delays. Reshop reports that merchants using its platform see repeat purchases happening about twice as fast and worth roughly one-fifth more than the original refunded amount, highlighting how faster refunds can potentially deepen loyalty and lift...

North Dallas Bank & Trust (NODB) just wrapped up FY 2025 with fourth quarter total revenue of US$12.9 million and basic EPS of US$1.19, capping a trailing twelve month stretch that sums to US$48.0 million in revenue and EPS of US$3.35. Over the past few quarters, revenue has moved from US$9.8 million in Q3 2024 to US$12.9 million in Q4 2025. Quarterly EPS has ranged from US$0.20 in Q3 2024 to US$1.19 most recently, alongside reported profit growth of 166.6% and a net profit margin that...

Everest Group: recent share performance in focus Everest Group (EG) has been under renewed scrutiny after a recent stretch of weaker share performance, with the stock down about 7% over the past week and 9% over the past year. That softer run sits against a last close near $318.81 and mixed fundamentals, including annual revenue of about $17.7b and net income of $547.0m, which give investors concrete figures to weigh against recent price moves. See our latest analysis for Everest...

Context for Daktronics stock after recent performance moves Daktronics (DAKT) has drawn attention after a recent share price of $21.69 and a 1 day return decline of about 1%. Investors are weighing this against the company’s multi year total return record. See our latest analysis for Daktronics. While Daktronics’ latest 1 day share price return of about a 1% decline has cooled the move, a 30 day share price return of 14.04% and a very large 3 year total shareholder return suggest longer term...

Wondering if Vital Farms at around US$29.49 is offering genuine value or just looks interesting on the surface? This article walks through what the current price might be implying. The stock is down 1.9% over the last week and 8.4% over the last month, and its 31.6% decline over the past year contrasts with a 74.9% return over three years and 19.3% over five years. These mixed returns have kept Vital Farms on many investors' watchlists, as they weigh shorter term pullbacks against longer...

Recent performance snapshot for Bank OZK Bank OZK (OZK) has attracted fresh attention after recent share price moves, with the stock showing modest changes over the past week, month and past 3 months, as well as a more extended record over 1 and 5 years. See our latest analysis for Bank OZK. The recent 90-day share price return of 5.53% and year to date share price return of 3.10% suggest momentum has been building gradually, while the 1-year total shareholder return of 1.34% shows a more...

United Parks & Resorts recently announced that SeaWorld returned in early 2026 with an expanded coast-to-coast live music series, offering full-length concerts by artists such as Flo Rida, Boyz II Men, and The Beach Boys in Orlando, San Diego, and San Antonio at no extra cost beyond park admission. This move places live entertainment at the center of the guest experience and is designed to deepen Annual Pass value by giving members flexible, season-long access to multiple concerts across...

In Q4 2025, Select Medical Holdings Corporation disclosed spending US$630,000 on lobbying related to regulations for long-term acute care hospitals, inpatient rehabilitation facilities, and outpatient rehabilitation clinics, with a particular focus on Medicare payment issues, while institutional investors showed mixed positioning and analysts recently issued positive ratings. This combination of targeted policy engagement and favorable analyst sentiment highlights how regulatory influence...